Exploring Eye Vergence Markers ADHD) and ASD

Launched by ELIZABETH KILBEY · Mar 12, 2025

Keywords

ClinConnect Summary

This clinical trial is studying how eye movements, specifically eye vergence (which helps us see in 3D), might be linked to attention in children and adults with Attention Deficit Hyperactivity Disorder (ADHD) and Autism Spectrum Disorder (ASD). Researchers are using computer-based eye-tracking tasks to see how well these eye movements can help identify different types of attention problems. They hope that by understanding the relationship between eye vergence and attention, they can help detect attention issues earlier and provide better-targeted treatments.

To participate, individuals aged 6 and older are welcome, whether they have been diagnosed with ADHD or ASD or are part of a control group without these conditions. Participants will take part in eye-tracking tasks, and the study will also explore using smartphone cameras for tracking eye movements. It's important to note that individuals with certain vision issues, like uncorrected eyesight problems or other eye disorders, cannot participate. This research is focused on learning more about how attention works in people with ADHD and ASD, rather than testing a medical device for diagnosis or treatment.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Clinical Groups: Patients currently undergoing or who have previously undergone an assessment for either ADHD and/or Autism at either the CAN centre or Dr Kilbey's private practice in Beckenham.
• • Control Group: Subjects without a diagnosis of either ADHD nor Autism, who show no traits of these conditions.
• • People of any gender/sex who are aged older than 6 years old.
• Exclusion Criteria:
• • Those with non-corrected vision - e.g. near-sightedness, far-sightedness, strabismus or nystagmus
• • Individuals with any other oculomotor deficiency, blindness or vision loss.